Skip to content
LongevityGraded

Clinics & testing

NOVOS vs Tally Health: Which Longevity Brand Is Worth It?

NOVOS sells a multi-pathway longevity supplement; Tally Health sells an epigenetic-age test plus its own pill. A graded, honest head-to-head on what's proven.

Researched & graded by · Lead Reviews Analyst
Updated
On this page

Evidence graded in this piece

  • A0strong
  • B2mixed
  • C2thin
How we grade
B

Featured partner

Grade B

CoreAge Rx

Clinician-reviewed NAD+ and sermorelin with published starting prices and human support. Confirm the full cost and renewal terms before paying.

$93–$99/mo (starting rates)

We may earn a commission through this link, at no extra cost to you.

Check availability
Pricing
Varies by plan
Pharmacy
503A compounding pharmacy
Labs
Depends on treatment
Consult
Clinician review included
Support
Human support included

Grades come from each provider's published terms. How we're funded

B

Partner

Grade B

Eden

The widest longevity menu here — quoted entirely as first-month prices, over a membership that goes from $39 to $99.

First month from $91 NAD+, + $39 then $99/mo membership

We may earn a commission through this link, at no extra cost to you.

Visit Eden

Every published longevity figure is a FIRST-MONTH price, and the ongoing medication rate is published nowhere. Compounded and not FDA-approved. Graded on the same rubric as every other provider on our scorecard.

The one-sentence version

These two brands look like rivals, but they're really selling different things: NOVOS sells you a once-daily multi-ingredient longevity powder, while Tally Health sells you a number — an at-home epigenetic-age test — wrapped in a coaching membership that points you back toward its own supplement. Pick by which question you're trying to answer, then read the same honest caveat under both: neither has shown, in a human outcome trial, that buying it makes you age slower or live longer. Core now has preliminary randomized human evidence on vascular function; a biological-age test answers a different question. We grade each in depth in our NOVOS review and Tally Health review; this page is the side-by-side.

What each one actually sells

The category confusion starts here, so it's worth being blunt. NOVOS is a product: a daily drink mix bundling roughly a dozen ingredients, each picked to nudge a recognized hallmark of aging. Core itself is a supplement purchase, distinct from the separately sold NOVOS Age test. Tally Health is a service plus a product: a DNA-methylation cheek-swab test that returns a biological-age estimate, a membership dashboard that tracks that estimate over time, and an own-brand pill the program nudges you toward. Tally currently offers testing, supplements and memberships with action plans; check the contents of the selected offer.6

Head to head

What it is~12-ingredient daily longevity drinkEpigenetic-age test + membership + supplement
Testing component?Separate NOVOS Age productDNA-methylation cheek swab
Price$98 monthly; $950 prepaid annualCheck the specific test or subscription offer
Design / science logicEach ingredient mapped to a hallmark of agingEpigenetic clock with real population science
Best evidenceSmall randomized vascular-marker trialMethylation clocks predict mortality in cohorts
Predicts YOUR outcome?No proven lifespan benefitNo — clock not a validated personal target
Pushes a supplement?It is the supplementYes (Tally supplement) — no human longevity proof
Different products entirely: NOVOS sells a multi-pathway blend, Tally sells a number plus its own blend. Neither has earned an anti-aging outcome claim.

That structural difference matters more than any ingredient debate. With NOVOS, you're paying for convenience and a multi-pathway thesis. With Tally, you're paying for measurement first — which sounds more rigorous, until you ask whether the measurement can actually tell you anything actionable.

Grading the evidence, side by side

We hold both to the same bar: separate mechanism from human outcome, and never let a clever design or a famous name stand in for proof. For the full rubric, see how we grade longevity providers.

NOVOS Core now has finished-product human evidence. The six-month randomized, double-blind STAMINA study assigned 61 adults to Core or control; 43 completed both visits. It reported improvements in flow-mediated dilation, arterial stiffness and systolic blood pressure, with unchanged lipids. The accepted manuscript was published in European Heart Journal Open on September 28, 2026. These are vascular markers, not proof of fewer cardiovascular events or longer life; incomplete follow-up and the need for independent replication limit certainty.4 Our STAMINA trial analysis explains the design and results. Ingredient studies such as GlyNAC remain a separate evidence layer: Core contains glycine without the NAC partner.1

Tally's case is top-down. The epigenetic clock underneath is legitimate population science — methylation-age testing predicts mortality across large cohorts2, and the most credible pace-of-aging clock was even slowed by a randomized caloric-restriction intervention in the CALERIE trial3. The catch is what that science licenses: predicting outcomes across thousands of people is a different claim from telling one buyer whether a protocol moved their personal risk. No clock has been validated as a modifiable individual target, and single-test reproducibility noise can rival the change a short routine produces.

So the two land in different failure modes. Core has preliminary randomized vascular findings, without demonstrated lifespan benefit. Tally is real science aimed at a use case it hasn't been validated for — and it bundles a supplement that faces the same need to demonstrate meaningful long-term health benefits.

Graded scorecard

  1. B
    Core human vascular evidenceModerate evidence

    One small randomized Core trial reported favorable vascular markers; it did not establish lifespan extension.

  2. B
    Tally's epigenetic-clock technology (population science)Moderate evidence

    Methylation clocks predict mortality across cohorts; the pace-of-aging clock was slowed by randomized caloric restriction in CALERIE. Real — but population-level, not a personal verdict.

  3. C
    Tally as a personal protocol-tracking membershipWeak evidence

    No clock is validated as a modifiable individual target, and single-test reproducibility noise can rival the change a short routine produces. The retest-and-optimize loop isn't supported.

  4. D
    Either supplement as a proven anti-aging interventionInsufficient

    Neither the NOVOS blend nor Tally's supplement has a randomized human-outcome trial showing it extends lifespan. Mechanism and population data are not proof in the individual buyer.

Same bar for both. Core's vascular evidence and population clock research address different questions; Tally's personal-tracking use case is weak; the proven-anti-aging claim is none for both supplements.

Compare the testing offers separately from Core

Testing is separate from the Core drink; NOVOS also sells NOVOS Age separately. Here, compare what each purchase actually includes. A biological-age readout is seductive: a single number that feels like a verdict on how you're aging. Used once, as a soft risk signal from a credible brand, it's a defensible curiosity. The trouble is the membership model, which encourages you to retest every few months to "watch your number drop" — precisely the use case the evidence doesn't support, because an apparent improvement may be measurement wobble rather than biology. And when the same company sells both the test and the pill meant to improve it, an unvalidated readout quietly becomes a sales tool. Our free blood-based PhenoAge calculator offers a different kind of estimate from methylation testing. The methods are not interchangeable, and neither turns a score change into proof of a treatment benefit.

Cost, and who each suits

For Core alone, the advertised US offers checked October 15, 2026 are $109 once, $98 monthly, $559 prepaid for six boxes or $950 prepaid for twelve. A box contains 30 daily servings. The long plans renew automatically and require upfront payment; applicable tax or checkout charges may add to the total.5 Tally's test and subscription charges are different purchase categories. We do not quote a current Tally price in this comparison; verify the included tests, supplements and renewal total for the specific offer.

  • Lean toward NOVOS if you want one convenient multi-pathway formula instead of ten separate jars, you've read the evidence, and you accept preliminary vascular evidence without expecting proven lifespan extension.
  • Lean toward Tally if your real itch is curiosity about a one-time epigenetic snapshot from a credible founder — and you'll read the number as a soft signal, skip the obsessive retesting, and not reorganize your spending around the Tally supplement subscription.
  • Skip both if you're expecting either to demonstrably slow your aging. Prioritize exercise and appropriate preventive medical care before spending on an uncertain longevity benefit.

For a broader view of what's actually worth buying in this category, see our best longevity supplements roundup, and for a testing-first brand graded the same way, our Superpower Health review.

The verdict

How to choose between them

  • They're not true rivals — NOVOS sells a multi-pathway supplement; Tally sells a biological-age test that funnels you toward its own supplement. Pick by the question you're answering.
  • Neither has a human outcome trial showing it slows your aging. NOVOS's formula and Tally's clock-science are both genuinely thoughtful, but thoughtful is not proven.
  • Consider Core if you want a daily blend and accept preliminary vascular evidence. Choose Tally only for a one-time snapshot from a credible founder — skip the retest-driven membership.
  • Compare the specific test, supplement and membership included in each offer; Core and NOVOS Age are separate purchases.
  • Keep exercise and preventive health care ahead of optional longevity purchases.

Bottom line

Core and Tally's testing offer serve different purposes. Core provides a fixed daily supplement and has a small randomized trial of vascular markers. An epigenetic-age test provides an estimate that needs cautious interpretation. Neither purchase has demonstrated human lifespan extension. Choose on the service included, the full recurring cost and the limits of the evidence. Read our NOVOS review and Tally Health review before making a commitment.

Frequently asked questions

Is NOVOS or Tally Health better for longevity?

Neither has demonstrated human lifespan extension. Core has a small randomized human study reporting favorable vascular markers; Tally offers biological-age testing, which is a different use case. Match the purchase to your goal and read the limitations in each full review.

What's the main difference between NOVOS and Tally Health?

Core is a daily multi-ingredient drink. NOVOS Age is a separate test product; it is not included in Core. Tally sells a service plus a product: a DNA-methylation biological-age test, a membership that tracks your number over time, and an own-brand supplement (Tally supplement) the program nudges you toward. NOVOS asks you to trust a blend; Tally asks you to trust a clock, then sells you a blend too.

Does Tally Health's biological-age test make it worth more than NOVOS?

The test is Tally's real differentiator, and as a one-time curiosity from a credible brand it's defensible. But epigenetic clocks are validated to predict outcomes across large populations, not to tell you personally whether an intervention worked, and single-test noise can rival the change a short routine produces. The membership encourages frequent retesting — exactly the use case the evidence doesn't support — and pairs it with a supplement that has no human longevity proof. A free blood-based PhenoAge calculator gives a comparable number without the subscription.

Which is cheaper, NOVOS or Tally Health?

Core costs $109 once, $98 monthly, $559 prepaid for six boxes or $950 prepaid for twelve at advertised US prices checked October 15, 2026. Each box supplies 30 daily servings. A current Tally price is not quoted here; compare the exact included products, tests and renewal charges.

References

  1. Kumar P, Liu C, Suliburk J, et al. (2023). Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Insulin Resistance, Endothelial Dysfunction, Genotoxicity, Muscle Strength, and Cognition. Journals of Gerontology Series A.
  2. Marioni RE, Shah S, McRae AF, et al. (2015). DNA methylation age of blood predicts all-cause mortality in later life. Genome Biology.
  3. Waziry R, Ryan CP, Corcoran DL, et al. (2023). Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nature Aging.
  4. Piercy C, Harris J, Sackho K, et al. (2026). Acute and 6-Month Vascular Effects of a Multi-Component Nutritional Supplement: Preliminary Findings from a Randomised Controlled Trial. European Heart Journal Open — published accepted manuscript.
  5. NOVOS (2026). Core plan prices (accessed October 15, 2026). NOVOS.
  6. Tally Health (2026). Testing, supplements and membership overview (accessed October 15, 2026). Tally Health.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.